Immupharma PLC Holding(s) in Company (6800O)
November 09 2016 - 2:01AM
UK Regulatory
TIDMIMM TIDMLGEN
RNS Number : 6800O
Immupharma PLC
09 November 2016
RNS : FOR IMMEDIATE RELEASE 9 NOVEMBER 2016
NOTIFICATION OF MAJOR INTEREST BY LEGAL & GENERAL
ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the
specialist drug discovery and development company, announces that
it has received notification by Legal & General Group Plc
("L&G") confirming its holding in ImmuPharma of 4,285,714
million Ordinary Shares in the capital of the Company, representing
3.43% of ImmuPharma's total voting rights.
Commenting, Tim McCarthy, Chairman of ImmuPharma, said: "We are
delighted to be able to disclose Legal & General as one of the
new significant and major institutional investors which
participated in ImmuPharma's recent successful vendor placing. One
of the Board's priorities is to maintain and strengthen our
shareholder base. We are therefore delighted that such a highly
regarded institution as Legal & General has demonstrated its
support for ImmuPharma."
Full disclosure of the TR1 is shown below:
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
--------------------------------------------------------------------------------------------------
1. Identity of the issuer or Immupharma Plc
the underlying issuer
of existing shares to which
voting rights are
attached:
------------------------------------------------------------ ------------------------------------
2. Reason for the notification (please tick the appropriate
box or boxes):
--------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights Yes
-------------------------------------------------------------------------------------------- ----
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached.
-------------------------------------------------------------------------------------------- ----
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
-------------------------------------------------------------------------------------------- ----
An event changing the breakdown of voting rights Yes
-------------------------------------------------------------------------------------------- ----
Other (please Placement of 2,857,143 shares
specify):
-------------------------------------------------------- ---------------------------------- ----
3. Full name of person(s) Legal & General Group Plc
subject to the (L&G)
notification obligation:
---------------------------------------------------------- --------------------------------------
4. Full name of shareholder(s)
(if different from 3.): Legal & General Assurance
Society Limited (LGAS & LGPL)
---------------------------------------------------------- --------------------------------------
21 October 2016
5. Date of the transaction
and date on
which the threshold is
crossed or
reached:
---------------------------------------------------------- --------------------------------------
6. Date on which issuer 28 October 2016
notified:
---------------------------------------------------------- --------------------------------------
7. Threshold(s) that is/are L&G (Above 3%)
crossed or
reached:
---------------------------------------------------------- --------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------ ------------------------------------------------ ----------------------------------------------------------------
Number Number Number of voting % of voting
of of rights rights
Shares Voting
Rights
------------ ---------------- ------------------------------ -------------------------- ---------------------
Number Direct Indirect Direct Indirect
of shares
------------ ------------ ------------ ------------ ------------- ------------- ----------- --------- ----------
ORD GBP First notification
0.10 under DTR Sourcebook 4,285,714 4,285,714 - 3.43% -
------------ ------------------------------------------------ ------------- ------------- ----------- --------- ----------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------------------------
Number of voting
Type of Expiration Exercise/ rights that % of voting
financial date Conversion may be rights
instrument Period acquired if
the
instrument
is
exercised/
converted.
---------------- ---------------- ------------------------------------------- -------------------------- -------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights
instrument period refers to
-------------- ---------------- -------------- -------------- ---------------------------- --------------------------------
Nominal Delta
-------------- ---------------- -------------- -------------- ---------------------------- -------------------- ----------
Total (A+B+C)
--------------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
---------------------------------------------------------------- --------------------------------------------------------------
4,285,714 3.43%
---------------------------------------------------------------- --------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
--------------------------------------------------------------------------------------------------------------------
Legal & General Group Plc (Direct and
Indirect) (Group) (Below 5% = Total
Position)
Legal & General Investment Management
(Holdings) Limited (LGIMH) (Direct and
Indirect) (Below
5% = Total Position)
Legal & General Investment Management
Limited (Indirect) (LGIM) (Below 5% = Total
Position)
Legal & General Group Plc (Direct) (L&G) (4,285,714, 3.43% = LGAS, LGPL & PMC)
Legal & General Investment Management Legal & General Insurance Holdings Limited
(Holdings) Limited (Direct) (LGIMHD) (Direct) (LGIH) (4,285,714, 3.43% = LGAS &
LGPL)
Legal & General Assurance (Pensions Legal & General Assurance Society Limited
Management) Limited (PMC) (LGAS & LGPL) (4,285,714, 3.43% = LGAS &
LGPL)
Legal & General Pensions Limited (Direct)
(LGPL)
Proxy Voting:
--------------------------------------------------------------------------------------------------------------------
10. Name of the proxy holder: N/A
----------------------------------------------------------------------------- -------------------------------------
11. Number of voting rights proxy N/A
holder will cease
to hold:
----------------------------------------------------------------------------- -------------------------------------
12. Date on which proxy holder will N/A
cease to hold
voting rights:
----------------------------------------------------------------------------- -------------------------------------
Notification using the total
13. Additional information: voting rights figure of 124,638,362
----------------------------------------------------------------------------- -------------------------------------
14. Contact name: Victoria Davies (LGIM)
----------------------------------------------------------------------------- -------------------------------------
15. Contact telephone number: 029 2035 4147
----------------------------------------------------------------------------- -------------------------------------
-Ends-
For further information please
contact:
+ 44 (0) 20
ImmuPharma plc (www.immupharma.org) 7152 4080
Tim McCarthy, Chairman
Lisa Baderoon, Head of Investor
Relations + 44 (0) 7721
Twitter: @immupharma 413496
Panmure, Gordon & Co., (NOMAD +44 (0) 20
& Broker) 7886 2500
Freddy Crossley, Duncan Monteith,
Corporate Finance
Charles Leigh-Pemberton, Corporate
Broking
Northland Capital Partners Limited
(Joint Broker)
Patrick Claridge, David Hignell,
Corporate Finance
Rob Rees, John Howes, Corporate +44 (0)20 3861
Broking 6625
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBVLLBQFFLFBQ
(END) Dow Jones Newswires
November 09, 2016 02:01 ET (07:01 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2023 to Apr 2024
